Reshma Kewalramani - Feb 16, 2024 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
CEO & President, Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 16, 2024
Transactions value $
-$6,920,361
Form type
4
Date filed
2/21/2024, 04:29 PM
Previous filing
Feb 13, 2024
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$3.97M -9.36K -5.77% $424.01 153K Feb 16, 2024 Direct
transaction VRTX Common Stock Tax liability -$2.95M -7.02K -4.59% $420.58 146K Feb 20, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.